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Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is a common liver disease associated with inactivity and obesity. Physical
activity and exercise could affect the risk of NAFLD progression by improving the hepatic lipid profiles.
Objectives: The current study aimed to evaluate the efficacy of combination of aerobic and resistance training on hepatic enzymes
in males with NAFLD.
Patients and Methods: The study was a randomized controlled trial. Thirty-two untrained males with NAFLD (aged = 32.93± 2.15
years, weight = 86.01.51± 8.40 kg) were recruited and randomly divided into equal experimental and control groups. The trained
group took part in a combination aerobic and resistance training program for eight weeks (three times per week). The control group
continued their routine life. The weight, body mass index (BMI) and serum levels of total cholesterol (TC), triglycerides (TG), low
density lipoprotein (LDL), high density lipoprotein (HDL), very low density lipoprotein (VLDL), HDL/LDL, TC/HDL, aspartate amino-
transferase (AST) and alanine transaminase (ALT) were measured before and after the protocol.
Results: Statistical analysis demonstrated that the training group had significant changes in weight, BMI, TC, TG, LDL, VLDL, HDL/LDL,
TC/ HDL, AST and ALT, whereas there was no significant change in HDL in NAFLD patients (P < 0.05).
Conclusions: The results suggest that physical activity improves metabolic parameters, which interfere in the development of fatty
liver and has a protective role against the development of NAFLD.
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1. Background
Nonalcoholic fatty liver disease (NAFLD) is one of the
common liver diseases (1) strongly linked to lifestyle habits
(2). The prevalence of NAFLD in the general population
of Western countries is 20% - 30%, whereas, it is 6.3% - 33%
worldwide (3). In Asian countries it is 12% - 24% (4) and
the prevalence of NAFLD in South and North of Iran is 21.5%
(5) and 43.8% (6), respectively. The most common cause
of liver disease in Iran is likely NAFLD (7). The most pre-
dictive factors of NAFLD are metabolic syndrome and obe-
sity, which are increasing in Iran (8); therefore, the preva-
lence of NAFLD is predicted to increase in the future. The
prevalence of NAFLD increases with increasing waist-to-
hip circumference ratio (WHR) (9). Racial background in-
fluences the relationship between body mass index (BMI)
and NAFLD (10). Also high risk of developing dyslipi-
demia [(high plasma triglycerides (TG) and/or low plasma
high-density lipoprotein cholesterol (HDL)], diabetes type
2 and hypertension could be associated with NAFLD. Be-
sides overweight, alanine aminotransferase (ALT) and as-
partate aminotransferase are markers of liver dysfunction
(11). Studies suggested that the fatty liver metabolic param-
eters could improve by lifestyle modification by increasing
physical activity and changing bad eating habits (12, 13);
therefore the relationship between physical activity (PA)
and liver enzyme levels aspartate aminotransferase (AST)
and AST/ALT are shown (11, 14). Haus et al. noted that short-
term exercise reduces the risk of NAFLD progression by im-
proving the hepatic lipid profiles (15). The differences of
HDL concentrations between athletes and sedentary show
the beneficial effects of exercise on NAFLD (16).
2. Objectives
There are several studies on the effect of different meth-
ods of exercise and different subject on NAFLD. The current
study aimed to evaluate the efficacy of combination of aer-
obic and resistance training on males with NAFLD.
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3. Patients andMethods
3.1. Subjects
The current study was conducted from April to June
2015 under the auspices of the Islamic Azad university Na-
jafabad branch. The study was approved by the research
ethics committee of Isfahan University of Medical Science
and health services (IUMS) (No. 494128). All subjects were
volunteers and signed a written informed consent.
3.2. Study Design
The study was randomized controlled trial. Thirty-two
untrained males with NAFLD (mean age = 32.93±2.15 years,
weight = 86.01.51 ± 8.40 kg and BMI= 28.21 ± 0.19 kg/m2)
were randomly selected out of 48 eligible male volunteers
with NAFLD. They were randomly divided into two equal
groups, experimental (E) and control (C). The inclusion
criteria were male with NAFLD diagnosis and not to have
taken part in regular exercises for at least six months prior
to enrollment. The exclusion criteria were any orthopedic
problem that would interfere with the protocol of train-
ing.
The training group took part in a combination of aer-
obic and resistance training programs for eight weeks
(three times per week). The duration of each session was
60 minutes divided into four sections consisting of 10 min-
utes warm-up, 10 minutes aerobic training, 30 minutes re-
sistance training, and 10 minutes cool-down. The warm-up
section consisted of stretching movements and rhythmic
movements with low intensity. The aerobic training sec-
tion consisted of rhythmic movements and the resistance
training section consisted of three sets of 8 - 12 repetitions
at 60% - 80 % of maximum voluntary contraction (MVC) (17)
in biceps, triceps, pectoralis, quadriceps, and hamstring
muscles in the position of dumbbell biceps (seated concen-
tration curl), dumbbell triceps (triceps kickback), bench
press, knee extension and knee flexion, respectively. The
subjects had three minutes rest after completing the three
sets.
The intensity of aerobic training was 65% - 85% heart
rate reserve (HRR) by the Polar FT4 HR Monitor and the in-
tensity of resistance training was 60% - 80 % MVC. The cool-
down section consisted of rhythmic movements with low
intensity and stretching movements with deep breathing.
The control group continued their normal lifestyle. There
was no dropped outs due to the study.
3.3. Anthropometric Measurements
The digital scale (Seca Bella 840, Seca GmbH and Co,
Hamburg, Germany) was used to measure body weight
(BW) To measure height, the stadiometer was used (0.1 cm
precision) (Seca, Modell 214, Hamburg, Germany). Quetelet
index (kg/m2) was used to calculate BMI (18).
3.4. Blood Sample Measurement
Venous blood samples were obtained from the antecu-
bital vein of the subjects in a seated position before and af-
ter the intervention. The blood samples were collected at
the same time of the day to reduce any diurnal variation of
the hormonal response. Following the overnight fasting of
9 - 12 hours, the subjects came to the laboratory from 7:00
to 8:00 am, and took a rest for 30 minutes prior to the first
blood collection. The serum levels of TG, total cholesterol
(TC) (6), low density lipoprotein (LDL), HDL, AST and ALT
were measured by ROSHE full automated auto-analyzer us-
ing Pars Azmoon kits. Very low density lipoprotein (VLDL)
by the formula VLDL = TG/5, and also the ratio TC/ HDL and
HDL/ LDL were calculated.
3.5. Statistical Analysis
Relevant statistical analyses were performed using
SPSS version 15 on a personal computer; P < 0.05 was con-
sidered as the level of significance. Descriptive analyses
were adopted for demographic and clinical characteristics
and reported as means± SD. Before the statistical analysis
Kolmogorov-Smirnov test was used to determine the nor-
mality of the distributions (P > 0.05), and the Levene test
was used to show homogeneity of variances between the
two groups before the start of the protocol (P > 0.05). Dif-
ferences among groups were assessed by analysis of covari-
ate (ANCOVA) (P < 0.05).
4. Results
Thirty-two subjects completed the training pro-
gram and the follow-up test in the experimental group.
Kolmogorov-Smirnov test showed the normal distribution
of the variables (P > 0.05), and the Levene test showed
homogeneity of variances between the two groups before
the start of the protocol reported in Table 1 (P > 0.05).
The thirty-two patients with NAFLD recruited for the in-
vestigation, completed the study. Demographic and clini-
cal characteristics are shown in Table 2. There were no sig-
nificant differences in the baseline of age, weight and BMI
between the two groups (P≤0.05). The means of lipid pro-
files components and liver enzymes before and after eight
weeks in both groups are presented in Table 1 (P≤ 0.05).
The ANOVA test demonstrated that after the eight
weeks of combined aerobic and resistance training, the E
group had 2.25% significant decrease in weight, 2.01% in
BMI, 8.48% in LDL, 3.07% in TC, 7.44% in TG, 7.44% in VLDL,
11.09% in TC/ HDL, 12.32% in AST, 12.85% in ALT, and 6.09% sig-
nificant increase in HDL/LDL, but there was no significant
change in the HDL (P≤ 0.05) (Table 1).
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Table 1. Blood Test Results of the Study Subjects Before and After Eight Weeks of Combination Aerobic and Resistance Training Programa
Variables Pre-test Post-test LevenTest F P ηb Observed Power
Weight, kg 0.06 61.24 0.01* 0.66 1.00
E 86.05± 8.77 84.11± 8.78
C 85.97± 8.02 86.73± 8.11
BMI, Kg.m-1 0.07 9.82 0.01* 0.24 0.86
E 28.35± 2.73 27.78± 2.57
C 27.65± 1.85 28.07± 1.79
TC,mg.dL-1 0.05 12.98 0.00* 0.30 0.93
E 234.56± 32.78 252.25± 26.79
C 233.43± 21.14 227.50± 19.74
TG,mg.dL-1 0.05 4.53 0.04* 0.13 0.53
E 237.87± 53.79 238.68± 51.77
C 260.62± 38.23 291.87± 62.56
LDL,mg.dL-1 0.20 33.13 0.00* 0.53 1.00
E 153.43± 16.47 147.06± 14.82
C 148.00± 17.38 178.50± 28.11
HDL,mg.dL-1 0.12 2.54 0.12 0.08 0.33
E 34.30± 6.63 35.38± 7.58
C 41.07± 13.50 32.98± 17.71
VLDL,mg.dL-1 0.05 4.53 0.04* 0.13 0.53
E 47.77± 10.75 47.53± 10.35
C 52.12± 7.64 58.37± 12.51
HDL/ LDL 0.84 15.01 0.00* 0.34 0.96
E 0.22± 0.05 0.24± 0..06
C 0.28± 0.22 0.18± 0..09
TC/ HDL 0.12 8.03 0.00* 0.21 0.78
E 7.11± 1.93 6.68± 1.51
C 8.29± 4.96 9.58± 4.91
AST, U.L-1 0.96 86.22 0.01* 0.74 1.00
E 97.88± 48.89 85.82± 39.80
C 70.11± 44.77 75.70± 48.47
ALT, U.L-1 0.98 91.01 0.01* 0.77 1.00
E 54.94± 13.17 47.88± 11.62
C 52.23± 17.57 57.84± 21.57
Abbreviations: AST, aspartate aminotransferase; ALT, alanine transaminase; BMI, body mass index; C, control group; E, exercise group; HDL, high density lipoprotein; TC,
total cholesterol; TG, triglycerides; LDL, low density lipoprotein; VLDL, very low density lipoprotein.
aNumber of control group and exercise group = 16, df = 1,30.
bη, Partial eta-squared (demonstrated the changes of variable); observed power (to indicate an adequate number of subjects); values are mean± SD.
5. Discussion
Obesity is the background of the diseases, and NAFLD is
concomitant with it, moreover decreased physical activity
and the lack of controlled calorie intake impact on the pro-
gressive disease process (19). The NAFLD’s prevalence has
increased, especially in the middle aged subjects (20), and
often occurs more in males than females (21).
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Table 2. Demographic Data of Subjects in the Experimental and Control Groupsa
Variables Experimental Group Control Group
Age, y 34.46± 7.29 31.41± 8.89
Weight, kg 86.05± 8.77 85.97± 8.02
BMI , kg.m-1 28.35± 2.73 28.07± 1.79
aNo. = 16
In results of the current study showed a significant de-
crease in BW, BMI, LDL and TC, TG, LDL, VLDL, TC/HDL and
significant increase in HDL/LDL after eight weeks of physi-
cal training in males with fatty liver, whereas there was no
significant change in the HDL. Although there were signif-
icant changes in many variables, the changes did not lead
to a desirable point. Pinto et al. noted significant decrease
in BM, HDL and TG levels in active males with fatty liver (12).
Also Khaoshbaten showed significant decrease of lipid pro-
files after three months of aerobic exercise (22). Zelber-Sagi
et al. noted the adjustment of body mass index and signif-
icant decrease in lipid profiles and body composition after
resistance training in patients with NAFLD (23).
The current study results indicated significant de-
crease of AST and ALT, which was in line with those of Hazar
et al. (24) and Khaoshbaten et al. (22); they reported signifi-
cant decrease of AST and ALT in patients with NAFLD follow-
ing exercise training. Hallsworth et al. demonstrated that
eight weeks of resistance exercise specifically improves
NAFLD by 13% and relative reduction in liver lipid, without
any changes in BW and FM (25).
Habitual physical activity enhances hepatic fatty acid
oxidation and reduces fatty acid synthesis (26). Histolog-
ical features of NAFLD have an inverse relationship with
fat oxidation (27). Incomplete lipid oxidation in the high-
fat-diet leads to metabolic deregulation by including β-
oxidation elevation, which is not matched with enhanced
Krebs cycle activity. The accumulation of acetyl Co-A, in the
cell cytosol or leak into plasma may impact on mitochon-
drial oxidative stress factors or insulin sensitivity which
have important roles in hepatic function (28). Koves et
al. also found that exercise training increased the flux of
both β-oxidation and Krebs cycle in both liver and skele-
tal muscles (29). Ordonez suggested that weight loss as-
sociated with exercise and proper diet is the main factor
to prevent and treat NAFLD (30). Fat oxidation as a domi-
nate energy resource in physical activity with mild to mod-
erate intensity improves hepatic lipid composition. The
first step in the NAFLD management is lifestyle modifica-
tion (30). Therefore, lifestyle is a main factor with progres-
sive effects on NAFLD, whereas health-related fitness (HRF),
physical activity (PA) are beneficial factors are necessary to
improve lifestyle and reduce the associated risk factors of
NAFLD (14).
In conclusion, the prevalence of NAFLD has recently in-
creased due to the rise of obesity and diabetes type 2, af-
fected by lifestyle changes and industrialization. There-
fore, lifestyle modifications are the best strategy to prevent
and control NAFLD. Exercise as a valid and low-cost therapy
could be added to NAFLD therapies to adjust fatty liver dis-
orders.
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